HomeAVIR • NASDAQ
add
Atea Pharmaceuticals Inc
Previous close
$3.20
Day range
$3.13 - $3.22
Year range
$2.75 - $4.14
Market cap
273.68M USD
Avg Volume
284.48K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 13.36M | 15.85% |
Net income | -33.54M | 14.35% |
Net profit margin | — | — |
Earnings per share | -0.40 | 14.89% |
EBITDA | -35.16M | -22.23% |
Effective tax rate | -0.68% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 454.72M | -21.34% |
Total assets | 464.67M | -21.90% |
Total liabilities | 25.80M | -35.13% |
Total equity | 438.87M | — |
Shares outstanding | 85.53M | — |
Price to book | 0.62 | — |
Return on assets | -18.45% | — |
Return on capital | -19.57% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -33.54M | 14.35% |
Cash from operations | -30.40M | -39.22% |
Cash from investing | -3.37M | -112.13% |
Cash from financing | 0.00 | — |
Net change in cash | -33.77M | -668.76% |
Free cash flow | -17.78M | -603.56% |
About
Founded
2012
Headquarters
Website
Employees
56
